- Home
- KOD vs PRG Comparison
KOD vs PRG Comparison
Compare KOD & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | PRG |
|---|---|---|
| Founded | 2009 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KOD | PRG |
|---|---|---|
| Price | $25.28 | $40.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $28.29 | ★ $37.67 |
| AVG Volume (30 Days) | ★ 656.3K | 453.1K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | ★ 32.60 | N/A |
| EPS | N/A | ★ 3.59 |
| Revenue | N/A | ★ $2,409,223,000.00 |
| Revenue This Year | N/A | $9.99 |
| Revenue Next Year | N/A | $5.92 |
| P/E Ratio | ★ N/A | $11.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.92 | $23.50 |
| 52 Week High | $31.18 | $41.14 |
Technical Indicators
Market Signals| Indicator | KOD | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 77.48 |
| Support Level | $21.51 | $32.61 |
| Resistance Level | $27.99 | $41.14 |
| Average True Range (ATR) | 2.02 | 1.56 |
| MACD | 0.33 | 0.56 |
| Stochastic Oscillator | 66.67 | 86.04 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.